Nebraska Raises Stakes in Battle With FDA, Won't Surrender Supply of Controversial Drug
4/24/2012 7:41:57 AM
The state of Nebraska, engaged in an ongoing battle with the US Food and Drug Administration (FDA) over its supply of an controversial anesthetic drug used in executions, confirmed it will defy an FDA order to hand over remaining supplies of sodium thiopental, reports The Associated Press. In a statement released 20 April, Nebraska’s state attorney general’s office said they believed a court order, issued by Federal District Court Judge Richard Leon, was incorrect. Leon’s order found supplies of sodium thiopental, an anesthetic and integral part of a three-drug cocktail used in executions, to have been improperly imported in violation of FDA’s enforcement discretion.
comments powered by